Intrinsic Value of S&P & Nasdaq Contact Us

MedAvail Holdings, Inc. MDVL NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Pharmaceuticals • CA • USD

SharesGrow Score
27/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MedAvail Holdings, Inc. (MDVL) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 25/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
27/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — MDVL

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-36.20
Book Value / Share$0.00
Revenue / Share$32.77
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2013 $-1,926.23 $3.32M $-4.26M -128.5%
2014 $-1,825.10 $3.34M $-5.21M -155.8%
2015 $-391.51 $159K $-5.07M -3191.2%
2016 $-225.81 $327K $-4.34M -1327.5%
2017 $-172.68 $526K $-4.06M -771.5%
2018 $-121.08 $360K $-3.22M -895.3%
2019 $-691.29 $3.77M $-22.27M -590.5%
2020 $-228.38 $13.97M $-26.14M -187.1%
2021 $-67.08 $22.13M $-43.82M -198%
2022 $-36.20 $43.11M $-47.62M -110.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message